Given its critical role in oligodendrocyte development and its downregulation in MS, Piezo1 represents a promising therapeutic target for promoting remyelination and restoring white matter integrity in demyelinating diseases. This evidence concerns the gene PIEZO1 and myeloid sarcoma.